InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,531.29
(
0.40%
)
US TECH 100
19,620.00
(
0.72%
)
Dow Jones
39,262.90
(
-0.18%
)
Brent Oil
86.24
(
-0.24%
)
Bitcoin
60,537.29
(
-2.40%
)
Post# of 252472
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 94630

Friday, 04/23/2010 8:39:34 AM

Friday, April 23, 2010 8:39:34 AM

Post# of 252472
HER2
Current testing methods (FISH is considered the gold standard) aren't accurate enough and better tests are definitely needed. Furthermore, we do not fully understand the link between HER2 gene copy number (which is what FISH is testing for) and Herceptin treatment since less than 50% of HER2+ metastatic breast tumors respond to Herceptin monotherapy and some HER2- do respond. So, better tests (in sequence we trust!) and their clinical relevance as well.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up